More Cancer Mutations, Better Immunotherapy Outcomes
More Cancer Mutations, Better Immunotherapy Outcomes
Immune checkpoint inhibitors are generally most effective against tumors with more genetic mutations, according to a new study, although the relationship isn’t true for all cancers.
More Cancer Mutations, Better Immunotherapy Outcomes
More Cancer Mutations, Better Immunotherapy Outcomes

Immune checkpoint inhibitors are generally most effective against tumors with more genetic mutations, according to a new study, although the relationship isn’t true for all cancers.

Immune checkpoint inhibitors are generally most effective against tumors with more genetic mutations, according to a new study, although the relationship isn’t true for all cancers.

survey, developmental biology, disease & medicine, culture
Image of the Day: Breathe In
Image of the Day: Breathe In
Carolyn Wilke | Jan 14, 2019
Inhalable particles carrying mRNA make mouse lungs glow.
Exosomes Linked to Cancer Spread from Chemoresistant Tumors in Mice
Exosomes Linked to Cancer Spread from Chemoresistant Tumors in Mice
Carolyn Wilke | Jan 10, 2019
The vesicles promote metastasis after chemotherapy, but the authors say the results shouldn’t alarm patients and may point to ways to improve treatments.
New York Faces Worst Measles Outbreak in Decades
New York Faces Worst Measles Outbreak in Decades
Catherine Offord | Jan 10, 2019
In one county alone, more than 100 cases have been confirmed since October.
US Cancer Death Rate Dropped for 25 Years Starting in 1991
US Cancer Death Rate Dropped for 25 Years Starting in 1991
Carolyn Wilke | Jan 9, 2019
Better treatment and diagnoses have helped more people survive, but economic disparities in outcomes for some preventable cancers have gotten worse.
Newly Identified Virus Similar to Ebola, Marburg
Newly Identified Virus Similar to Ebola, Marburg
Kerry Grens | Jan 9, 2019
Menglà virus, detected in bats in China, infects cells through the same host receptor targeted by the deadly pathogens.
Leader of Evo-Devo Field, Rudy Raff, Dies
Leader of Evo-Devo Field, Rudy Raff, Dies
Jef Akst | Jan 9, 2019
The Indiana University professor was known for his research on the evolution of organismal development.
Eli Lilly Will Buy Loxo Oncology for $8 BillionEli Lilly Will Buy Loxo Oncology for $8 Billion
Eli Lilly Will Buy Loxo Oncology for $8 Billion
Ashley Yeager | Jan 8, 2019
Loxo focuses on cancer treatments based on tumor genetics, which will contribute to Lilly’s push in the cancer drug space.
AI App Identifies Rare Genetic Disorders from Photos of Patients’ Faces
AI App Identifies Rare Genetic Disorders from Photos of Patients’ Faces
Catherine Offord | Jan 8, 2019
Deep-learning algorithms could help doctors narrow in on the causes of certain medical conditions, say researchers.
Image of the Day: It’s a Shark!
Image of the Day: It’s a Shark!
Carolyn Wilke | Jan 8, 2019
A newly developed underwater ultrasound reveals a fetal shark swimming between the two uteri of its mother.